_id
690f3ad5ccc777a4e85d197b
Ticker
CAH
Name
Cardinal Health Inc
Exchange
NYSE
Address
7000 Cardinal Place, Dublin, OH, United States, 43017
Country
USA
Sector
Healthcare
Industry
Medical Distribution
Currency
USD
Website
https://www.cardinalhealth.com
Description
Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The company also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; pharmacy management services to hospitals; operates pharmacies, including pharmacies in community health centers; and repackages generic pharmaceuticals and over-the-counter healthcare products. In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compression, incontinence, nutritional delivery, and wound care products; single-use surgical drapes, gowns, and apparel products; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. Further, the company distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile and non-sterile procedure kits. Additionally, it manufactures, prepares, and delivers radiopharmaceuticals; and optimizes direct shipments through integrated technology solutions. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.
Last Close
198.18
Volume
817818
Current Price
199.96
Change
0.898173377737411
Last Updated
2025-11-29T11:07:04.483Z
Image
-
Ipo Date
1987-12-31T00:00:00.000Z
Market Cap
50431922176
Next Dividend Date
2026-01-15T00:00:00.000Z
Dividend Frequency
Quarterly
Dividend Rate
0.5107
Dividend Yield
1.0216043208641727
Sentiment
0.9884553571428573
Sentiment Sources
56
Rating
4.1177
Target Price
214.7143
Strong Buy
9
Buy
2
Hold
5
Sell
1
Strong Sell
0
Current Quarter
2025-09-30
Revenue
64009000000
Cost Of Revenue
61690000000
Gross Profit
2319000000
Operating Expenses
1651000000
Operating Income
668000000
Interest Expense
80000000
Pretax Income
598000000
Net Income
450000000
Eps
1.8828451882845187
Dividends Per Share
-129000000
Shares Outstanding
237595042
Income Tax Expense
144000000
EBITDA
911000000
Operating Margin
1.0436032432939117
Total Other Income Expense Net
-70000000
Cash
4593000000
Short Term Investments
-
Receivables
13770000000
Inventories
17559000000
Total Current Assets
38537000000
Property Plant Equipment
2831000000
Total Assets
55228000000
Payables
36860000000
Short Term Debt
52000000
Long Term Debt
8980000000
Total Liabilities
57959000000
Equity
-2879000000
Depreciation
233000000
Change In Working Capital
173000000
Cash From Operations
973000000
Capital Expenditures
108000000
Cash From Investing
-142000000
Cash From Financing
-110000000
Net Change In Cash
719000000
PE
32.0634
PB
-16.599666550885726
ROE
-15.630427231677665
ROA
0.8148040848844789
FCF
865000000
Fcf Percent
0.01351372463247356
Piotroski FScore
3
Health Score
31
Deep Value Investing Score
3
Defensive Investing Score
6.5
Dividend Investing Score
5.5
Economic Moat Investing Score
7.3
Garp Investing Score
5.5
Growth Investing Score
5.5
Momentum Investing Score
5.5
Net Net Investing Score
2
Quality Investing Score
4
Value Investing Score
1.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
64009000000
Quarters > 0 > income Statement > cost Of Revenue
61690000000
Quarters > 0 > income Statement > gross Profit
2319000000
Quarters > 0 > income Statement > operating Expenses
1651000000
Quarters > 0 > income Statement > operating Income
668000000
Quarters > 0 > income Statement > interest Expense
80000000
Quarters > 0 > income Statement > pretax Income
598000000
Quarters > 0 > income Statement > net Income
450000000
Quarters > 0 > income Statement > eps
1.8828451882845187
Quarters > 0 > income Statement > dividends Per Share
-129000000
Quarters > 0 > income Statement > shares Outstanding
239000000
Quarters > 0 > income Statement > income Tax Expense
144000000
Quarters > 0 > income Statement > EBITDA
911000000
Quarters > 0 > income Statement > operating Margin
1.0436032432939117
Quarters > 0 > income Statement > total Other Income Expense Net
-70000000
Quarters > 0 > balance Sheet > cash
4593000000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
13770000000
Quarters > 0 > balance Sheet > inventories
17559000000
Quarters > 0 > balance Sheet > total Current Assets
38537000000
Quarters > 0 > balance Sheet > property Plant Equipment
2831000000
Quarters > 0 > balance Sheet > total Assets
55228000000
Quarters > 0 > balance Sheet > payables
36860000000
Quarters > 0 > balance Sheet > short Term Debt
52000000
Quarters > 0 > balance Sheet > long Term Debt
8980000000
Quarters > 0 > balance Sheet > total Liabilities
57959000000
Quarters > 0 > balance Sheet > equity
-2879000000
Quarters > 0 > cash Flow > net Income
454000000
Quarters > 0 > cash Flow > depreciation
233000000
Quarters > 0 > cash Flow > change In Working Capital
173000000
Quarters > 0 > cash Flow > cash From Operations
973000000
Quarters > 0 > cash Flow > capital Expenditures
108000000
Quarters > 0 > cash Flow > cash From Investing
-142000000
Quarters > 0 > cash Flow > cash From Financing
-110000000
Quarters > 0 > cash Flow > net Change In Cash
719000000
Quarters > 0 > ratios > PE
1.8828451882845187
Quarters > 0 > ratios > PB
-16.599666550885726
Quarters > 0 > ratios > ROE
-15.630427231677665
Quarters > 0 > ratios > ROA
0.8148040848844789
Quarters > 0 > ratios > FCF
865000000
Quarters > 0 > ratios > Piotroski FScore
3
Quarters > 0 > ratios > fcf Percent
0.01351372463247356
Quarters > 0 > health Score
31
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
60159000000
Quarters > 1 > income Statement > cost Of Revenue
57957000000
Quarters > 1 > income Statement > gross Profit
2202000000
Quarters > 1 > income Statement > operating Expenses
1774000000
Quarters > 1 > income Statement > operating Income
428000000
Quarters > 1 > income Statement > interest Expense
74000000
Quarters > 1 > income Statement > pretax Income
384000000
Quarters > 1 > income Statement > net Income
239000000
Quarters > 1 > income Statement > eps
0.9958333333333333
Quarters > 1 > income Statement > dividends Per Share
-120000000
Quarters > 1 > income Statement > shares Outstanding
240000000
Quarters > 1 > income Statement > income Tax Expense
141000000
Quarters > 1 > income Statement > EBITDA
667000000
Quarters > 1 > income Statement > operating Margin
0.7114479961435529
Quarters > 1 > income Statement > total Other Income Expense Net
-44000000
Quarters > 1 > balance Sheet > cash
3874000000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
13242000000
Quarters > 1 > balance Sheet > inventories
16831000000
Quarters > 1 > balance Sheet > total Current Assets
36373000000
Quarters > 1 > balance Sheet > property Plant Equipment
2858000000
Quarters > 1 > balance Sheet > total Assets
53122000000
Quarters > 1 > balance Sheet > payables
34713000000
Quarters > 1 > balance Sheet > short Term Debt
714000000
Quarters > 1 > balance Sheet > long Term Debt
7977000000
Quarters > 1 > balance Sheet > total Liabilities
55756000000
Quarters > 1 > balance Sheet > equity
-2781000000
Quarters > 1 > cash Flow > net Income
243000000
Quarters > 1 > cash Flow > depreciation
209000000
Quarters > 1 > cash Flow > change In Working Capital
633000000
Quarters > 1 > cash Flow > cash From Operations
1527000000
Quarters > 1 > cash Flow > capital Expenditures
232000000
Quarters > 1 > cash Flow > cash From Investing
-1643000000
Quarters > 1 > cash Flow > cash From Financing
668000000
Quarters > 1 > cash Flow > net Change In Cash
548000000
Quarters > 1 > ratios > PE
0.9958333333333333
Quarters > 1 > ratios > PB
-17.256526429341964
Quarters > 1 > ratios > ROE
-8.594030924128012
Quarters > 1 > ratios > ROA
0.44990775949700684
Quarters > 1 > ratios > FCF
1295000000
Quarters > 1 > ratios > Piotroski FScore
3
Quarters > 1 > ratios > fcf Percent
0.021526288668362172
Quarters > 1 > health Score
32
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
54878000000
Quarters > 2 > income Statement > cost Of Revenue
52755000000
Quarters > 2 > income Statement > gross Profit
2123000000
Quarters > 2 > income Statement > operating Expenses
1393000000
Quarters > 2 > income Statement > operating Income
730000000
Quarters > 2 > income Statement > interest Expense
74000000
Quarters > 2 > income Statement > pretax Income
665000000
Quarters > 2 > income Statement > net Income
506000000
Quarters > 2 > income Statement > eps
2.099585062240664
Quarters > 2 > income Statement > dividends Per Share
-124000000
Quarters > 2 > income Statement > shares Outstanding
241000000
Quarters > 2 > income Statement > income Tax Expense
157000000
Quarters > 2 > income Statement > EBITDA
946000000
Quarters > 2 > income Statement > operating Margin
1.3302234046430264
Quarters > 2 > income Statement > total Other Income Expense Net
-65000000
Quarters > 2 > balance Sheet > cash
3326000000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
12666000000
Quarters > 2 > balance Sheet > inventories
16158000000
Quarters > 2 > balance Sheet > total Current Assets
34595000000
Quarters > 2 > balance Sheet > property Plant Equipment
2664000000
Quarters > 2 > balance Sheet > total Assets
49871000000
Quarters > 2 > balance Sheet > payables
32812000000
Quarters > 2 > balance Sheet > short Term Debt
543000000
Quarters > 2 > balance Sheet > long Term Debt
7136000000
Quarters > 2 > balance Sheet > total Liabilities
51769000000
Quarters > 2 > balance Sheet > equity
-2948000000
Quarters > 2 > cash Flow > net Income
508000000
Quarters > 2 > cash Flow > depreciation
207000000
Quarters > 2 > cash Flow > change In Working Capital
2175000000
Quarters > 2 > cash Flow > cash From Operations
2917000000
Quarters > 2 > cash Flow > capital Expenditures
126000000
Quarters > 2 > cash Flow > cash From Investing
-2898000000
Quarters > 2 > cash Flow > cash From Financing
-507000000
Quarters > 2 > cash Flow > net Change In Cash
-484000000
Quarters > 2 > ratios > PE
2.099585062240664
Quarters > 2 > ratios > PB
-16.346797829036635
Quarters > 2 > ratios > ROE
-17.16417910447761
Quarters > 2 > ratios > ROA
1.0146177137013495
Quarters > 2 > ratios > FCF
2791000000
Quarters > 2 > ratios > Piotroski FScore
3
Quarters > 2 > ratios > fcf Percent
0.05085826742957105
Quarters > 2 > health Score
35
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
55264000000
Quarters > 3 > income Statement > cost Of Revenue
53323000000
Quarters > 3 > income Statement > gross Profit
1941000000
Quarters > 3 > income Statement > operating Expenses
1392000000
Quarters > 3 > income Statement > operating Income
549000000
Quarters > 3 > income Statement > interest Expense
35000000
Quarters > 3 > income Statement > pretax Income
511000000
Quarters > 3 > income Statement > net Income
400000000
Quarters > 3 > income Statement > eps
1.646090534979424
Quarters > 3 > income Statement > dividends Per Share
-122000000
Quarters > 3 > income Statement > shares Outstanding
243000000
Quarters > 3 > income Statement > income Tax Expense
110000000
Quarters > 3 > income Statement > EBITDA
738000000
Quarters > 3 > income Statement > operating Margin
0.993413433700058
Quarters > 3 > income Statement > total Other Income Expense Net
-38000000
Quarters > 3 > balance Sheet > cash
3810000000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
12369000000
Quarters > 3 > balance Sheet > inventories
16904000000
Quarters > 3 > balance Sheet > total Current Assets
35756000000
Quarters > 3 > balance Sheet > property Plant Equipment
2558000000
Quarters > 3 > balance Sheet > total Assets
47002000000
Quarters > 3 > balance Sheet > payables
31298000000
Quarters > 3 > balance Sheet > short Term Debt
544000000
Quarters > 3 > balance Sheet > long Term Debt
7062000000
Quarters > 3 > balance Sheet > total Liabilities
49923000000
Quarters > 3 > balance Sheet > equity
-2991000000
Quarters > 3 > cash Flow > net Income
401000000
Quarters > 3 > cash Flow > depreciation
192000000
Quarters > 3 > cash Flow > change In Working Capital
-1039000000
Quarters > 3 > cash Flow > cash From Operations
-400000000
Quarters > 3 > cash Flow > capital Expenditures
99000000
Quarters > 3 > cash Flow > cash From Investing
-976000000
Quarters > 3 > cash Flow > cash From Financing
2331000000
Quarters > 3 > cash Flow > net Change In Cash
943000000
Quarters > 3 > ratios > PE
1.646090534979424
Quarters > 3 > ratios > PB
-16.245496489468405
Quarters > 3 > ratios > ROE
-13.373453694416584
Quarters > 3 > ratios > ROA
0.8510276158461342
Quarters > 3 > ratios > FCF
-499000000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-0.009029386218876665
Quarters > 3 > health Score
30
Valuation > metrics > PE
32.0634
Valuation > metrics > PB
-16.599666550885726
Valuation > final Score
41.52392
Valuation > verdict
28.3% Overvalued
Profitability > metrics > ROE
-15.630427231677665
Profitability > metrics > ROA
1.1677089550302306
Profitability > metrics > Net Margin
0.007030261369494915
Profitability > final Score
5
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
8.35
Risk > final Score
63
Risk > verdict
High
Liquidity > metrics > Current Ratio
1.0440236237537928
Liquidity > metrics > Quick Ratio
0.5683246640658864
Liquidity > final Score
55
Liquidity > verdict
Weak
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
3
Prev Profitabilities > 1
6
Prev Profitabilities > 2
4
Prev Risks > 0
53
Prev Risks > 1
69
Prev Risks > 2
70
Prev Liquidities > 0
53
Prev Liquidities > 1
54
Prev Liquidities > 2
58
Updated At
2025-12-16T22:29:21.425Z
Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The company also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; pharmacy management services to hospitals; operates pharmacies, including pharmacies in community health centers; and repackages generic pharmaceuticals and over-the-counter healthcare products. In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compression, incontinence, nutritional delivery, and wound care products; single-use surgical drapes, gowns, and apparel products; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. Further, the company distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile and non-sterile procedure kits. Additionally, it manufactures, prepares, and delivers radiopharmaceuticals; and optimizes direct shipments through integrated technology solutions. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.
Stock Price
$ 0.00
0% increase compared to yesterday.
Dividend
Frequency:
Rate:
0.5107Next Payout:
Jan 15, 2026Yield:
1.0216 %Cardinal Health (CAH): Assessing Valuation After a Recent Pullback in the Share Price simplywall.st
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
BUY
Target Price:
$214.7143
Analyst Picks
Strong Buy
9
Buy
2
Hold
5
Sell
1
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Earnings Ratio (P/E)
-
Medium
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
* Institutions hold a combined 71.94% of the total shares of Cardinal Health Inc
1.
Vanguard Group Inc(12.8043%)
since
2025/06/30
2.
BlackRock Inc(12.7926%)
since
2025/06/30
3.
State Street Corp(5.3071%)
since
2025/06/30
4.
Vanguard Total Stock Mkt Idx Inv(3.133%)
since
2025/07/31
5.
Geode Capital Management, LLC(2.6756%)
since
2025/06/30
6.
FMR Inc(2.6278%)
since
2025/06/30
7.
Vanguard 500 Index Investor(2.4747%)
since
2025/07/31
8.
Morgan Stanley - Brokerage Accounts(2.2921%)
since
2025/06/30
9.
Vanguard Mid Cap Index Institutional(2.2297%)
since
2025/07/31
10.
Bank of America Corp(1.4578%)
since
2025/06/30
11.
NORGES BANK(1.4568%)
since
2025/06/30
12.
Amvescap Plc.(1.2721%)
since
2025/06/30
13.
Fidelity 500 Index(1.267%)
since
2025/07/31
14.
Northern Trust Corp(1.254%)
since
2025/06/30
15.
SPDR® S&P 500® ETF(1.21%)
since
2025/08/31
16.
iShares Core S&P 500 ETF(1.2028%)
since
2025/08/31
17.
UBS Asset Mgmt Americas Inc(1.0807%)
since
2025/06/30
18.
JPMorgan Chase & Co(1.0563%)
since
2025/06/30
19.
Legal & General Group PLC(0.984%)
since
2025/06/30
20.
Wellington Management Company LLP(0.96%)
since
2025/06/30
21.
BlackRock Equity Dividend Instl(0.9419%)
since
2025/07/31
22.
Vanguard Value Index Inv(0.8859%)
since
2025/07/31
23.
Marshall Wace Asset Management Ltd(0.8086%)
since
2025/06/30
24.
BlackRock Large Cap Core (SMA)(0.8033%)
since
2025/08/31
25.
T. Rowe Price Associates, Inc.(0.683%)
since
2025/06/30
26.
The Health Care Select Sector SPDR® ETF(0.6825%)
since
2025/08/31
27.
Goldman Sachs Group Inc(0.6698%)
since
2025/06/30
28.
Victory Capital Management Inc.(0.6602%)
since
2025/06/30
29.
Charles Schwab Investment Management Inc(0.6374%)
since
2025/06/30
30.
Vanguard Mid-Cap Value ETF(0.629%)
since
2025/07/31
31.
Bank of New York Mellon Corp(0.6168%)
since
2025/06/30
32.
Vanguard Institutional Index I(0.6039%)
since
2025/07/31
33.
Vanguard Windsor Investor Shares(0.5973%)
since
2025/06/30
34.
Vanguard Dividend Appreciation ETF(0.538%)
since
2025/07/31
35.
State St S&P 500® Indx SL Cl III(0.5335%)
since
2025/08/31
36.
Loomis Sayles Core(0.4606%)
since
2025/06/30
37.
ProShares S&P 500 Dividend Aristocrats(0.4463%)
since
2025/08/29
38.
Pacer US Cash Cows 100 ETF(0.4317%)
since
2025/08/29
39.
Vanguard High Dividend Yield ETF(0.3888%)
since
2025/07/31
40.
Invesco S&P 500® Equal Weight ETF(0.3859%)
since
2025/08/29
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.